Please login to the form below

Not currently logged in
Email:
Password:

Orion

This page shows the latest Orion news and features for those working in and with pharma, biotech and healthcare.

Bayer gets EU nod for prostate cancer drug Nubeqa

Bayer gets EU nod for prostate cancer drug Nubeqa

Enters an increasingly competitive market. Bayer and Orion have bagged approval from the European Commission (EC) for their new prostate cancer treatment Nubeqa, setting it up to rival other approved treatments ... Bayer and Orion reckon they have an

Latest news

More from news
Approximately 2 fully matching, plus 30 partially matching documents found.

Latest Intelligence

  • Deal Watch table for June 2014 Deal Watch table for June 2014

    75. Orion/ Bayer. Co-development, option to co-promote in Europe. OraQuick HCV rapid test in US.

  • Pharma deals during June 2014 Pharma deals during June 2014

    Financial terms were not disclosed but include milestone and royalties. Staying with the mid-caps and turning to prostate cancer, Bayer and Orion entered into a joint development deal for ... trials. Orion will retain co-promotion rights in Europe.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Orion appoints VP of oncology, R&D Orion appoints VP of oncology, R&D

    He said: “My new position at Orion allows me to maintain and deepen my research focus, which is to develop such treatments for cancer patients wherever they live. ... I hope that my long background in the academia will help in the initiation of new

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 19 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics